Meta-Research: Individual-level researcher data confirm the widening gender gap in publishing rates during COVID-19
Abstract
Publishing is part and parcel of a successful academic career, and Covid-19 has amplified gender disparities in manuscript submissions and authorships. We used longitudinal publication data on 431,207 scientists in biology, chemistry, and clinical and basic medicine to quantify the differential impact of Covid-19 on women's and men's annual publishing rates. In a difference-in-differences analysis, we estimated that the average gender difference in publication productivity increased from -0.26 in 2019 (corresponding to a 17% lower output for women than men) to -0.35 in 2020 (corresponding to a 24% lower output for women than men). An age-group comparison showed a widening gender gap for both early career and mid-career scientists. The increasing gender gap was most pronounced among highly productive authors and scientists in clinical medicine and biology. Our study demonstrates the importance of reinforcing institutional commitments to diversity through policies that support the inclusion and retention of women researchers.
Data availability
The current manuscript is a computational study, so no data have been generated for this manuscript. Source data and code will be provided on git-hub for all tables and figures.
Article and author information
Author details
Funding
Samfund og Erhverv, Det Frie Forskningsråd (DFF-0133-00165B)
- Emil Bargmann Madsen
- Mathias Wullum Nielsen
- Josefine Bjørnholm
- Jens Peter Andersen
Aarhus Universitets Forskningsfond (AUFF-F-2018-7-5)
- Jens Peter Andersen
Independent Research Fund Denmark (9130-00029B)
- Mathias Wullum Nielsen
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2022, Madsen et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,042
- views
-
- 271
- downloads
-
- 38
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
eLife’s Executable Research Article lets authors include live code, data and interactive figures in their published paper.
-
- Computational and Systems Biology
Artificial intelligence (AI) models have been used to study the compositional regularities of proteins in nature, enabling it to assist in protein design to improve the efficiency of protein engineering and reduce manufacturing cost. However, in industrial settings, proteins are often required to work in extreme environments where they are relatively scarce or even non-existent in nature. Since such proteins are almost absent in the training datasets, it is uncertain whether AI model possesses the capability of evolving the protein to adapt extreme conditions. Antibodies are crucial components of affinity chromatography, and they are hoped to remain active at the extreme environments where most proteins cannot tolerate. In this study, we applied an advanced large language model (LLM), the Pro-PRIME model, to improve the alkali resistance of a representative antibody, a VHH antibody capable of binding to growth hormone. Through two rounds of design, we ensured that the selected mutant has enhanced functionality, including higher thermal stability, extreme pH resistance, and stronger affinity, thereby validating the generalized capability of the LLM in meeting specific demands. To the best of our knowledge, this is the first LLM-designed protein product, which is successfully applied in mass production.